# Pandemic-driven immune imprinting accelerates evolution of human coronavirus OC43

**Authors:** Shuiping Lu, Qi Shen, Huanru Wang, Mingyi Cai, Jingjing Hu, Yi Li, Yuxi Wang, Feng Yuan, Qingyuan Xu, Weijie Chen, Yitian Wu, Jiasheng Xiong, Zheng Teng, Mengting Tang, Chenglong Xiong

PMC · DOI: 10.1371/journal.pntd.0014109 · PLOS Neglected Tropical Diseases · 2026-03-17

## TL;DR

The study shows that pandemic measures and immune responses may be driving rapid evolution in the human coronavirus OC43.

## Contribution

The study identifies accelerated genomic evolution in HCoV-OC43 post-2020 and links it to immune imprinting from pandemic interventions.

## Key findings

- HCoV-OC43's spike gene substitution rate increased 3.76-fold after 2020.
- Positively selected mutations in the spike protein overlap with antigenic epitopes.
- Structural modeling shows cross-binding of antibodies from SARS-CoV-2 to HCoV-OC43.

## Abstract

Global pandemic interventions have reshaped host-virus dynamics, potentially altering the evolution of endemic pathogens. Here, we report accelerated genomic evolution of human coronavirus OC43 (HCoV-OC43)—a close relative of pandemic-associated coronaviruses—following recent worldwide epidemiological shifts. Bayesian analysis of longitudinal surveillance data revealed a 3.76-fold increase (8.9403 × 10 ⁻ ⁴ nucleotide substitutions/site/year, 95% HPD: 4.9075 × 10 ⁻ ⁴, 1.3053 × 10 ⁻ ³) in the spike gene substitution rate of the currently dominant genotype K post-2020. Positively selected mutations were mainly located in the spike protein, and some colocalize with antigenic epitopes. Crucially, structural modeling demonstrated that broadly neutralizing antibodies targeting conserved stem-helix (S2P6) and fusion-peptide (COV44–62/79, 76E1) epitopes of high-pathogenicity betacoronaviruses cross-bind HCoV-OC43 spike protein, establishing a mechanistic basis for immune-driven selection. These findings suggest that population-level immune imprinting may play a potential driving role in mutations within key domains of HCoV-OC43, although further validation is required. Sustained co-surveillance of co-circulating coronaviruses is imperative to anticipate emergent variants with altered pathogenicity.

Since the global outbreak of COVID-19, extensive public health interventions—such as mask wearing, social distancing, and travel restrictions—along with widespread vaccination and antiviral treatments, have profoundly influenced the transmission dynamics of various respiratory viruses. HCoV-OC43 and SARS-CoV-2 both belong to the genus Betacoronavirus and share structural and antigenic similarities, which may lead to potential cross-reactivity and cross-protective immunity between them. The pandemic may have exerted immune selection pressures that drive adaptive mutations in HCoV-OC43, enabling it to maintain endemic circulation. However, current research on the molecular basis of cross-immunity between these coronaviruses and its impact on viral evolution remains limited. By comparing substitution rates and analyzing antigen–antibody interactions, our study revealed an accelerated evolutionary trend of HCoV-OC43 under potential immune selection pressure. These findings underscore the importance of ongoing joint surveillance of co-circulating coronaviruses to anticipate the emergence of new variants with altered pathogenicity.

## Linked entities

- **Genes:** CHMP5 (charged multivesicular body protein 5) [NCBI Gene 51510]
- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Genes:** ERVK-6 (endogenous retrovirus group K member 6, envelope) [NCBI Gene 64006] {aka ERVK6, HERV-K(C7), HERV-K108, K-Rev, c-orf, cORF}, ns12.9 (ns12.9) [NCBI Gene 39105219], N (nucleocapsid phosphoprotein) [NCBI Gene 43740575], VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}, ORF1ab (ORF1a polyprotein;ORF1ab polyprotein) [NCBI Gene 43740578], spike surface glycoprotein [NCBI Gene 39105218]
- **Diseases:** respiratory disease (MESH:D012140), COVID-19 (MESH:D000086382), infection (MESH:D007239), respiratory infections (MESH:D012141), pneumonia (MESH:D011014)
- **Chemicals:** Remdesivir (MESH:C000606551), COV44-62 (MESH:C000722697), COV44-79 (MESH:C000722696), Paxlovid (MESH:C000719967), hydrogen (MESH:D006859), 76E1 (-), Ritonavir (MESH:D019438), acid (MESH:D000143), EIDD-2801 (MESH:C000656703), Nirmatrelvir (MESH:C000718217)
- **Species:** Human coronavirus NL63 (no rank) [taxon 277944], Gammacoronavirus (genus) [taxon 694013], Human coronavirus OC43 (no rank) [taxon 31631], Human respiratory syncytial virus A (no rank) [taxon 208893], Human coronavirus HKU1 (no rank) [taxon 290028], Orthocoronavirinae (subfamily) [taxon 2501931], Alpharicinrhavirus blanchseco (species) [taxon 2843852], Bovine coronavirus (no rank) [taxon 11128], Mus musculus (house mouse, species) [taxon 10090], Betacoronavirus (genus) [taxon 694002], human respiratory syncytial virus (no rank) [taxon 11250], Human respiratory syncytial virus B (no rank) [taxon 208895], Bacillus sp. AT (species) [taxon 1196779], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome-related coronavirus (no rank) [taxon 694009], Middle East respiratory syndrome-related coronavirus (no rank) [taxon 1335626], Human coronavirus 229E (no rank) [taxon 11137]
- **Mutations:** P38L, D1251A, P265S, R26G, Y573H, D44E, N483D, P38L/S, L67V, L271S, C-10T, R26T, D614G, P265A, L481F, N33S, S270N, S40P, S265A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12994797/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12994797/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC12994797/full.md

---
Source: https://tomesphere.com/paper/PMC12994797